FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Antimicrobial Drugs Panel to Discuss Product Development

Federal Register notice: FDA announces a 4/13 Antimicrobial Drugs Advisory Committee meeting on developing antibacterial drugs that treat a single spe...

Human Drugs

FDA OKs 2 Gilead NDA Supplements for Hepatitis C

FDA approves two Gilead Sciences supplemental NDAs for Sovaldi (sofosbuvir) and Harvoni (ledipasvir and sofosbuvir) to treat hepatitis C virus in chil...

Human Drugs

GSK Recalls 593,000 Ventolin Asthma Inhalers

GlaxoSmithKline recalls 593,000 Ventolin HFA (albuterol sulfate) inhalation aerosol, 90 mcg per actuation (200 metered doses) due to a manufacturing d...

Human Drugs

FDA Approving Drugs Faster Than EMA: Analysis

Three researchers say that between 2011 and 2015, FDA approved new drugs more quickly than the European Medicines Agency.

Medical Devices

U.S. Companies Submitting Fewer 510(k)s: Consultants

Emergo reports that FDA 510(k) clearances were at a four-year low in 2016, as the number of applications from U.S. firms declined.

Human Drugs

Gottlieb Pledges Action on Opioid Crisis

FDA commissioner-nominee Scott Gottlieb says his highest immediate priority will be to assess whether the agency has adequate authorities and resource...

Human Drugs

FDA Clears Bausch + Lomb Vision Enhancement Device

FDA clears a Bausch + Lomb 510(k) for the Stellaris Elite Vision Enhancement System, the companys next generation phacoemulsification cataract platfor...

FDA General

WSJ Editorial Urges Quick Gottlieb Confirmation

A Wall Street Journal opinion piece dismisses Democrat lawmakers criticisms of FDA commissioner-nominee Scott Gottliebs close ties to industry, and ca...

Medical Devices

FDA OKs Genetic Risk Tests for Certain Conditions

FDA authorizes 23andMe to market genetic health risk tests that can indicate a genetic predisposition to any of 10 diseases or conditions.

Human Drugs

PhRMA Rebate Educational Campaign

PhRMA launches a campaign to educate consumers about drug rebates not passed on to them by health insurers.